Concepedia

Author

Héctor Luciardi

National University of Tucumán

Also Known As

Alberto Liberman, H Luciardi, HECTOR LUCAS LUCIARDI, Hector L Luciardi, Hector L. Luciardi, Hector Lucas Luciardi, Hector Luciardi, Héctor L Luciardi, Héctor L. Luciardi, Héctor Lucas Luciardi

65

Publications

3.1K

Citations

20

H-Index

21

Concepts

All Affiliations

National University of TucumánThrombosis Research InstituteUniversity College LondonBayer (Germany)Harvard University
HL

About

Héctor Luciardi is an author at National University of Tucumán specializing in medicine, pharmacotherapy, and atherosclerosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

1.7K

2

Diabetes

1

1

22

3

Emergency Medicine

1

1

749

4

Endocrinology

1

1

22

5

Neurology

1

1

855

Héctor Luciardi

×

16

Publications

2.3K

Citations

16

H-Index

YearCitations

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom,

The Lancet

2017

855

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch,

The Lancet

2017

749

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

Raúl Altman, Héctor Luciardi, Juan Muntaner,

Thrombosis Journal

2004

114

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek,

Circulation

2022

112

Efficacy Assessment of Meloxicam, a Preferential Cyclooxygenase-2 Inhibitor, in Acute Coronary Syndromes Without ST-Segment Elevation

Raúl Altman, Héctor Luciardi, Juan Muntaner,

Circulation

2002

109

Diagnosis, Management, and Treatment of Chronic Chagas' Heart Disease in Areas Where Trypanosoma cruzi Infection Is Not Endemic

Joaquím Gascón, Pedro Albajar, Elías Cañas,

Revista Española de Cardiología (English Edition)

2007

106

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand,

Journal of the American Heart Association

2019

54

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial

Gustavo Lopardo, Waldo Belloso, Esteban C. Nannini,

EClinicalMedicine

2021

52

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Gregory G. Schwartz, Michael Szarek, Vera Bittner,

Diabetes Care

2021

32

Diagnostic role of new Doppler index in assessment of renal artery stenosis

Sergio Chaín, Héctor Luciardi, Gabriela Feldman,

Cardiovascular Ultrasound

2006

27

Page 1